Vax trialled on Geelong residents approved in US
A vaccine for a common respiratory virus has been approved for use in America after being trialled on Geelong region residents. Barwon Health’s Adrian Costa Clinical Trials Centre recently collaborated with pharmaceutical and biotechnology company GSK on the world’s first respiratory syncytial virus (RSV) vaccine for older adults. The United States Food and Drug Administration … [Read more…]